Agouron Pharmaceuticals is Pharmaceuticals in United States that focus on chemicals that business. Founded in 1984. They cover business area such as developer, manufacturer, pharmaceutical, protein structure-base drug design, protein target, specific therapeutic need, large amount, genetic engineering technique, high-speed combinatorial chemistry technique, likely reactant.
1984
( 40 years old in 2024 )
Chemicals That
-
10350 North Torrey Pines Road
Suite 100
San Diego, CA 92037
United States
Private
developermanufacturerpharmaceuticalprotein structure-base drug designprotein targetspecific therapeutic needlarge amountgenetic engineering techniquehigh-speed combinatorial chemistry techniquelikely reactant
* We use standard office opening hours in near Agouron Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Agouron Pharmaceuticals is Pharmaceuticals business from United States that founded in 1984 (40 years old in 2024), Agouron Pharmaceuticals business is focusing on Chemicals That.
Agouron Pharmaceuticals headquarter office and corporate office address is located in 10350 North Torrey Pines Road Suite 100 San Diego, CA 92037 United States.
Agouron Pharmaceuticals was founded in United States.
In 2024, Agouron Pharmaceuticals is currently focus on chemicals that sector.
Above is snippet of Google Trends for "chemicals that" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Agouron Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
